For international pharmaceutical buyers, WHO GMP certification is an important consideration when evaluating a manufacturing or export partner. However, buyers should look beyond a certification name and understand what it means for manufacturing quality, documentation and export requirements.
Caritas Healthcare is an India-based global pharmaceutical company with a presence across 20+ countries and 5 continents. The company works with WHO GMP-certified manufacturing facilities and strategic manufacturing partners across India.
For importers and distributors, understanding WHO GMP can help create a more informed process when evaluating a pharmaceutical manufacturing or export partner.
WHO GMP stands for World Health Organization Good Manufacturing Practices.
GMP provides a framework for pharmaceutical manufacturing and quality control. It covers important areas such as production processes, quality control, documentation, personnel, facilities and equipment.
The purpose of GMP is to establish controlled manufacturing practices and consistent quality systems throughout pharmaceutical production.
GMP compliance demonstrates that pharmaceutical manufacturing follows established standards and controlled processes to support consistent product quality. For exporters, it also helps demonstrate alignment with internationally recognised quality requirements.
Pharmaceutical exports involve more than producing and shipping medicines. Buyers may need to consider manufacturing quality, product documentation and the regulatory requirements of their destination market.
WHO GMP can be an important part of this evaluation because it focuses on controlled manufacturing and quality practices.
For international buyers, key areas to consider include:
Manufacturing and quality-control processes
Product and batch documentation
Manufacturing-site credentials
Regulatory documentation
Destination-market requirements
Quality and compliance procedures
Supply and communication capabilities
WHO GMP is an important part of evaluating a pharmaceutical manufacturer or supplier, but it does not replace the specific regulatory and quality requirements of the importing country.
WHO GMP is connected to the systems and procedures used throughout pharmaceutical manufacturing.
Pharmaceutical manufacturing involves defined processes designed to maintain consistent quality. Appropriate procedures and documentation help manufacturers control production activities.
Quality control is an important part of pharmaceutical manufacturing. It involves appropriate testing and review of materials, processes and finished products according to established requirements.
Documentation provides a record of manufacturing and quality activities. Proper records can help manufacturers and buyers review production information when required.
Manufacturing facilities and equipment also form part of a pharmaceutical company's quality system. Their suitability, maintenance and controlled use are important considerations in pharmaceutical production.
No.
WHO GMP certification should not be treated as automatic approval to sell a pharmaceutical product in every international market.
Different countries may have their own requirements for pharmaceutical registration, documentation, labelling, manufacturing authorization and importation.
Therefore, exporters and importers should identify the applicable requirements for the specific destination market before finalizing a supply arrangement.
A buyer should verify:
The manufacturing facility involved
Current GMP documentation
The scope of the relevant certification
Product-specific documentation
Destination-country requirements
Any additional regulatory requirements
This helps create a clearer understanding of what the manufacturing certification covers and what additional steps may be required for the target market.
A professional supplier evaluation should involve more than checking whether a company mentions WHO GMP on its website.
Confirm which facility will manufacture the product and review the relevant manufacturing credentials.
Ask for the applicable certification and regulatory documentation and verify the issuing authority, scope and current status.
Depending on the product and destination market, buyers may require specific pharmaceutical and regulatory documents.
The importer and exporter should identify the requirements of the destination market before entering into a long-term supply arrangement.
Buyers should also consider manufacturing capability, documentation support, communication, supply capacity and regulatory experience when evaluating a pharmaceutical export partner.
At Caritas, we have built an international pharmaceutical business supported by a network of strategic manufacturing partnerships across India. We work with six world-class manufacturing plants across India and have access to WHO GMP-certified facilities.
The company states that it works with six world-class manufacturing plants across India and has access to WHO GMP-certified facilities.
Our international regulatory portfolio includes WHO GMP, USFDA, EU-GMP, MHRA-UK and ANVISA, along with other regulatory credentials. These certifications and approvals reflect our commitment to meeting stringent global standards across our pharmaceutical manufacturing and regulatory framework.
Our Global Reach & Capabilities
20+ countries of global presence
5 continents served
150+ professionals
250+ product registrations
6 manufacturing partnerships across India
WHO GMP-certified manufacturing facilities
Our global reach and integrated capabilities enable us to work with pharmaceutical distributors, importers and business partners across international markets, supporting the supply and registration of quality pharmaceutical products.
Before signing an export agreement, buyers can use the following checklist:
1. Manufacturing facilityConfirm the facility responsible for manufacturing the product.
2. GMP credentialsReview current GMP certification and relevant documentation.
3. Product scopeConfirm that the manufacturing and regulatory documentation is relevant to the product being sourced.
4. Regulatory requirementsUnderstand the requirements of the destination market.
5. Product documentationIdentify the documents required for registration, importation and supply.
6. Quality systemsUnderstand the supplier's approach to quality control and documentation.
7. Manufacturing capacityConfirm that the partner can support the expected order requirements.
8. CommunicationEstablish clear communication channels for commercial, quality and regulatory matters.
9. Supply planningDiscuss production and delivery expectations before finalizing the agreement.
10. Long-term suitabilityEvaluate whether the supplier can support the partnership as requirements develop.
WHO GMP certification is an important consideration when evaluating a pharmaceutical manufacturing or export partner. However, it should be viewed as part of a broader assessment that includes manufacturing capability, documentation, regulatory requirements and product-specific considerations.
For international buyers, the most practical approach is to verify the relevant certification, understand its scope and confirm the requirements of the destination market before signing an export agreement.
Caritas Healthcare provides pharmaceutical solutions across 20+ countries and 5 continents, supported by 150+ professionals, 250+ product registrations, and six strategic manufacturing partnerships across India. Our WHO GMP-certified manufacturing facilities and international regulatory capabilities support our commitment to delivering quality pharmaceutical solutions to global markets.
For distributors, importers and pharmaceutical businesses exploring international supply opportunities, Caritas Healthcare provides partnership and business inquiry channels to discuss specific requirements.